War on Disease
War on Disease
Invite
Back to Treatments
Treatment
Erenumab
1
Conditions
64
Trials
20K
Participants
65%
Average Safety
Condition Evidence
Migraine
64 trials Β· 20K participants
85% effectiveness Β· 65% safety
Erenumab | DFDA